Exelixis | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 119.69M 5.97M 2025-06
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
Amgen USD 8.7B 569M 2025-06
AstraZeneca USD 16.24B 1.42B 2025-06
Bayer EUR 17.64B 895M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Cytokinetics USD 8.41M 6.4M 2025-06
Eisai JPY 219.98B 42M 2025-06
Eli Lilly USD 17.21B 3.2B 2025-06
Exelixis USD 292.35M 10.72M 2025-07
Genmab DKK 998M 199M 2025-06
Glaxosmithkline GBP 7.7B 372M 2025-06
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 52.58M 12.87M 2025-06
MacroGenics USD 12.53M 8.22M 2025-06
Merck USD 12.72B 1.14B 2025-06
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 451M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
Sanofi 8.21B 2.42B 2025-06
Takeda JPY 679.53B 45.72B 2025-06
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
Xencor USD 47.55M 9.77M 2025-06


Exelixis Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.